Peroxisome Proliferator-Activated Receptor γ-Independent Repression of Prostate-Specific Antigen Expression by Thiazolidinediones in Prostate Cancer Cells-Reference-Cited by-同舟云学术

Peroxisome Proliferator-Activated Receptor γ-Independent Repression of Prostate-Specific Antigen Expression by Thiazolidinediones in Prostate Cancer Cells

Published:2006-02-01 Issue:5 Volume:69 Page:1564-1570
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Yang Chih-Cheng,Ku Chia-Yu,Wei Shuo,Shiau Chung-Wai,Chen Chang-Shi,Pinzone Joseph J.,Ringel Mathew D.,Chen Ching-Shih

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference24 articles.

1. Critical Role of c-Jun N-Terminal Protein Kinase Activation in Troglitazone-Induced Apoptosis of Human HepG2 Hepatoma Cells

2. Troglitazone, a Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand, Selectively Induces the Early Growth Response-1 Gene Independently of PPARγ

3. The Endocrinology and Developmental Biology of the Prostate*

4. Thiazolidinediones: a new class of antidiabetic drugs

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors;Cancer Cell International;2024-04-10

2. Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study;The World Journal of Men's Health;2023

3. AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin;International Journal of Molecular Sciences;2022-06-20

4. Antidiabetic medications and the risk of prostate cancer in patients with diabetes mellitus: A systematic review and meta-analysis;Pharmacological Research;2022-03

5. Thiazolidinedione: A Privileged Scaffold for the Development of Anticancer Agents;Current Topics in Medicinal Chemistry;2021-11